Abstract: Currently, toxicological testing of food contact materials (FCMs) is focused on single substances and their genotoxicity. However, people are exposed to mixtures of chemicals migrating from food contact articles (FCAs) into food, and toxic effects other than genotoxic damage may also be relevant. Since FCMs can be made of more than 8 thousand substances, assessing them one-by-one is very resource-consuming. Moreover, finished FCAs usually contain non-intentionally added substances (NIAS). NIAS toxicity can only be tested if a substance's chemical identity is known and if it is available as a pure chemical. Often, this is not the case. Nonetheless, regulations require safety assessments for all substances migrating from FCAs, including NIAS, hence new approaches to meet this legal obligation are needed. Testing the overall migrate or extract from an FCM/FCA is an option. Ideally, such an assessment would be performed by means of in vitro bioassays, as they are rapid and cost-effective. Here, we review the studies using in vitro bioassays to test toxicity of FCMs/FCAs. Three main categories of in vitro assays that have been applied include assays for cytotoxicity, genotoxicity, and endocrine disruption potential. In addition, we reviewed studies with small multicellular animal-based bioassays. Our overview shows that in vitro testing of FCMs is in principle feasible. We discuss future research needs and FCM-specific challenges. Sample preparation procedures need to be optimized and standardized. Further, the array of in vitro tests should be expanded to include those of highest relevance for the most prevalent human diseases of concern.
Introduction
During production, processing, packaging, transport, storage, preparation and serving, foods and beverages come into contact with food contact articles (FCAs) that are made up of various food contact materials (FCMs). Different chemicals can migrate from FCAs into foodstuffs, and thus be ingested. These so-called food contact chemicals (FCCs) comprise all chemicals, including those in nanoparticulate form, that constitute an FCM and are present in FCAs. It is estimated that FCCs originating from FCMs may occur in food at levels 100 times higher than pesticide residues or other environmental pollutants (Grob and others 2006) . However, despite the existence of dedicated legislation on chemical safety of FCMs in most countries (Magnuson and others 2013) , the health risks of exposure to FCCs remain insufficiently evaluated at present (Muncke 2009; Neltner and others 2013; CwiekLudwicka and Ludwicki 2014; Geueke and others 2014; Muncke and others 2014; Mertens and others 2016; Van Bossuyt and others 2016) .
The European framework regulation on FCMs requires that the substances migrating from FCMs and FCAs into food "do not harm" the consumer (EU 1935 , while in the U.S. CRF3-2017 -0045 Submitted 2/21/2017 , Accepted 5/25/2017 an FCC is considered safe when there is a "reasonable certainty in the minds of competent scientists that the substance is not harmful under the intended conditions of use" (21 CFR Part 170.3(i) ). However, due to the inherent technical and methodological difficulties in the safety assessment of FCMs, combined with significant knowledge gaps, compliance with these regulatory requirements may not be achievable presently (Grob 2014) .
Indeed, for the known starting substances, such as monomers and additives, safety is currently ensured by assessing the risk of each substance individually. However, for the so-called nonintentionally added substances (NIAS), which often form a significant part of the overall migrate (Grob 2014) , safety is much more difficult to ascertain (Nerin and others 2013; Koster and others 2015; Hoppe and others 2016) . NIAS comprise not only the impurities in the raw starting materials but also the newly formed substances, such as reaction by-products and unintended degradation products (Grob and others 2010) . Among the newly formed substances, some authors and organizations, including the International Life Sciences Institute (ILSI) tend to include oligomers in the NIAS definition (Koster and others 2015) , while others suggest to consider oligomers as a separate group of predictable polymer-specific substances (Hoppe and others 2016) . Chemical identification and toxicological testing of NIAS is highly timeand resource-consuming, and a complete characterization often remains impossible (Bradley and Coulier 2007; Bradley and others 2008; Nerin and others 2013; Hoppe and others 2016) .
In vitro toxicity testing of FCMs . . .
The issue is further complicated by the absence of the necessary analytical standards, which is the case for most oligomers (Hoppe and others 2016) and many other NIAS which, although identified chemically, cannot be tested toxicologically (Bengtstroem and others 2016) . Moreover, many NIAS remain completely unknown as they may escape even the chemical identification and/or confirmation (Bradley and Coulier 2007) , and thus the toxicological evaluation of these single substances cannot be performed per se.
Further, to ensure the absence of harm for consumers, risk assessment needs to take into account the mixture effects of all chemicals simultaneously present in FCMs (Muncke 2011b; Koster and others 2015) . The toxicity of mixtures is often evaluated and predicted based on the toxicity data available for single components of that mixture. However, such an approach may be particularly challenging to implement in case of the FCMs, due to the large number of potential migrants from a single FCM, lest the multicomponent and multilayer FCMs (Clemente and others 2016) , but also because the chemical identity may not be known for a substantial fraction of migrating NIAS (Bradley and Coulier 2007; Nerin and others 2013) , as discussed above. Indeed, it has been repeatedly demonstrated that the total toxicity of the overall migrate or extract from a given FCM is usually higher than the toxicity that can be predicted based on the known components of the mixture (Honkalampi-Hämäläinen and others 2010; Wagner and others 2013; Bengtstroem and others 2016) .
To address these challenges, a pragmatic, cost-efficient strategy could be to test overall migrates or extracts from finished FCMs or FCAs with a battery of relevant in vitro bioassays (Muncke 2011b; Koster and others 2015) . Indeed, biological (as opposed to chemical) characterization by means of in vitro tests may provide an integrated picture of various toxicological effects elicited by the mixture of all known, as well as unknown, substances potentially migrating from an FCM or an FCA (Eisenbrand and others 2002) . At the same time, these assays, usually miniaturized and requiring short processing times of 1 d to 1 wk, may cost less than the traditional in vivo tests, and be amenable to high throughput. Thus, in vitro bioassays may offer a robust and economic solution to screen the toxicity of FCMs and FCAs, and to assess the hazards of the overall migrates. The results of in vitro tests could be used directly to highlight those FCMs or components of FCAs that are problematic in terms of toxicological hazard, thus initiating a process for substituting chemicals of concern with more benign compounds. Alternatively, results of in vitro tests could be used to prioritize samples for further testing aimed at evaluating their potential to cause toxicity in vivo, to provide input data for a full risk assessment process.
Here we review studies that have used in vitro bioassays to test the toxicity of FCMs or FCAs, with the aim to summarize past experiences, identify knowledge gaps, and formulate future research and development needs.
FCM Testing In Vitro: Past Research
In vitro toxicity testing performed with FCMs has focused on 3 main types of toxicity, namely cytotoxicity (Table 1) , genotoxicity (Table 2) , and endocrine activity (Table 3 ). In addition, a few studies have tested FCMs with several whole-organism bioassays involving small multicellular animals. Such assays, still considered alternatives to conventional in vivo bioassays, offer high-throughput capabilities similar to the in vitro bioassays. Therefore, we have included these studies in our review as well (Table 4) .
FCM types that have been tested in vitro include virgin and recycled paper and paperboard, various plastics, coatings, and adhesives. To prepare the samples for in vitro bioassay testing, various protocols using different solvents and diverse time and temperature conditions have been applied. Franz and Stoermer (2008) divide the contact conditions into 2 categories, namely migration (when the conditions resemble the actual use), and extraction (when the conditions are chosen in such a way as to promote a strong interaction with an FCM, such as swelling for plastics, often resulting in a quicker mass transfer and equal or even exaggerated extents of migration). However, not all authors of the studies reviewed by us here have adhered to these definitions, sometimes referring to their contact conditions as "extraction" although they were chosen to represent the real use (Bradley and others 2008; Bradley and others 2010) , or vice versa. Current EU regulation for plastic FCMs recommends using the following food simulants in migration studies: 10% ethanol for aqueous foods, 3% acetic acid for acidic foods, 20% ethanol for alcoholic foods, 50% ethanol or vegetable oil for fatty foods, and Tenax to simulate the migration into dry foods (EC 2011). U.S. regulation recommends using 10% ethanol for aqueous and acidic foods, 10% and 50% ethanol for low-and high-alcoholic foods, respectively, and food oil or commercial triglyceride mixtures to simulate migration into fatty foods (FDA 2002) . These simulants and associated migration conditions are understood as providing the best simulation of migration from FCMs into food that occurs during real-life use. However, in the studies on in vitro testing of FCMs, other contact conditions and other simulants (for example, water, saline, 95% ethanol, isooctane) were often used as well. Moreover, since there are no clearly defined migration tests for most FCMs apart from plastics, the decision on whether a certain contact condition does or does not "represent real use" is prone to subjective judgements. Therefore, to avoid confusion, in the following text we refer to a particular sample preparation method as "migration" resulting in "migrates" or "overall migrates" to be used in toxicity tests, only if it was performed (i) with a plastic FCM and (ii) using solvents and conditions officially recommended in either the EU or U.S. for measuring the migration from plastic FCMs. All other sample preparation methods are referred to as "extraction", consequently resulting in "extracts" that were tested. Hence, depending on the solvents and conditions applied, many procedures that we refer to here as "extraction" in fact do not represent the "worse-case scenario" according to Franz and Stoermer (2008) , where the extraction is defined as a particularly strong interaction with the polymer. For clarity and further reference, we summarized the contact conditions and sample workup procedures used in each study in the respective tables (Table 1 to 4).
In the following subsections, we review the studies that have tested FCMs with the bioassays summarized in Table 1 to 4. The test results are referred to as "negative" if the tested endpoint was found to be unaffected; if a statistically significant effect on the assay endpoint was found, the test results are referred to as "positive."
It has to be noted that various nanomaterials, some also intended for application in food packaging (Maisanaba and others 2015) , have been extensively tested in a broad variety of in vitro assays (Guadagnini and others 2015; Ciappellano and others 2016) . Similarly, many other FCCs have also been tested in vitro as individual substances. However, the scope of this review is narrowly focused on testing only the overall migrates or extracts of FCMs as an approach to dealing with unknown substances and mixture toxicity. 
Cytotoxicity
Cytotoxicity assays represent the most basic type of in vitro bioassays. They assess chemical-induced damage resulting in cell death, effects on cell proliferation, or any other sublethal effects on the normal cell physiology and function, such as for example oxidative stress. Cytotoxicity assays that have been used for FCMs/FCAs testing are listed in Table 1A, and test results for various FCM  groups are summarized in Table 1B .
Cytotoxicity of paper and paperboard. Most studies looking at cytotoxicity of FCM extracts focused on paper and paperboard. Binderup and others (2002) used the resazurin reduction test in human neonatal foreskin fibroblasts to measure the cytotoxicity of water extract and ethanol extract of food contact papers containing different proportions of virgin and recycled fibers. Both types of extracts of all paper grades showed cytotoxicity. Cytotoxicity of the water extracts of all paper grades was comparable to that of the ethanol extract of the virgin paper. Cytotoxicity of the ethanol extracts of the papers with recycled content was 3 to 4 times higher than that of the virgin paper, coinciding with higher total concentrations of extracted chemicals (Binderup and others 2002) .
The European project BIOSAFEPAPER aimed to develop a battery of in vitro tests for toxicological assessment of paper and paperboard FCMs, focusing on cytotoxicity and genotoxicity (the latter reviewed in the respective section). In a pilot study, reference compounds were tested in order to select in vitro bioassays with the best sensitivity and a good qualitative agreement across several assays (Severin and others 2005) . The actual FCM testing was then carried out for several types of paper and board, 19 of them food-grade and 1 nonfood-grade (Bradley and others 2008; Honkalampi-Hämäläinen and others 2010) . Sample preparation conditions were selected based on the available information about the intended food type and condition of use, and included extraction with distilled water or 95% ethanol, or migration to poly(2,6-diphenol-p-phenylene oxide) (PPPO; Tenax), followed by Tenax extraction with 95% ethanol (Bradley and others 2008; Bradley and others 2010) . Bioassays for acute cytotoxicity included the total protein content (TPC) assay and the neutral red uptake (NRU) assay (Table 1A) . The TPC test was performed in a human larynx carcinoma cell line (HEp-2) and in a mouse hepatoma cell line (Hepa-1c1c7), and NRU was carried out in HEp-2 cells only. Sublethal cytotoxicity was measured with the boar spermatozoon motility test, and with the RNA synthesis inhibition assay (Table 1A) in a human hepatocarcinoma cell line (HepG2) and a human cervical cancer cell line (HeLa). None of the Tenax samples gave a positive response. Water extracts of the 2 food-grade paperboard samples were cytotoxic in the NRU assay but not in the other assays. Ethanol extracts of the 4 other samples, 3 foodgrade and 1 nonfood-grade, showed cytotoxicity in most of the assays used (Bradley and others 2008) . The strength of the toxicity often correlated with the total amount of extracted substances, but not always, as in some cases a higher total mass of extracted substances in water extracts did not result in higher toxicity compared with ethanol extracts. Hence, in the acute cytotoxicity assays with mammalian cell cultures, both water and ethanol extracts presented unique sampling-dependent toxicity profiles. In the sublethal toxicity assays, only the ethanol extracts showed toxicity, while water extracts had no effect (Bradley and others 2008) . However, in a study by Fauris and others (1998) , water extracts of paper and paperboard FCMs, both virgin and recycled, showed significant toxicity in the RNA synthesis inhibition assay in HeLa-S3 cells. In this study, cytotoxicity of water extracts ranged from very high (with RNA synthesis at 17% of the control) to nontoxic (RNA synthesis at 94% of the control). Moreover, recycled and virgin fibers showed the same level of cytotoxicity, both materials spanning the toxicity values over the entire range (Fauris and others 1998) . These findings demonstrate that the outcomes of a particular toxicity test may be case-or context-dependent, and cannot be generalized even for the same FCM type or extract type.
Cytotoxicity of coatings and adhesives. Mittag and others (2006) tested ethanol extracts of 2 types of can coatings, epoxy and polyester, with the 3 acute cytotoxicity assays, NRU, water-soluble tetrazolium salt -1 (WST-1) assay, and 5-bromo-2'-deoxyuridine (BrdU) DNA incorporation assay (Table 1A) . The 2 latter assays were performed in HeLa-S3 cells, and the NRU assay was performed in HepG2 cell line and 2 colorectal adenocarcinoma cell lines (Caco-2 and HT-29). The BrdU assay showed no significant effects on cell proliferation and thus proved to be the least sensitive. With the NRU assay in Caco-2, both coatings extracts were similarly cytotoxic, while in HepG2 and HT-29 only the epoxy coating showed significant cytotoxicity. In the WST-1 assay, both coating extracts were cytotoxic, with the epoxy coating showing a larger effect than polyester. In contrast, in the sublethal toxicity assay for RNA synthesis inhibition, the polyester coating was more toxic than epoxy coating (Mittag and others 2006) .
Within the MIGRESIVES project, ethanol extracts of 6 samples of laminates consisting of paperboard and various adhesives (one of each polyvinyl alcohol (PVOH)-and polyvinyl acetate (PVAC)-, and 4 acryl-based) were tested with the RNA synthesis inhibition assay in the HepG2 cell line (Stoermer and Franz 2009) . The extracts of the PVAC laminate and of the 3 acrylic laminates were found to be cytotoxic, but the toxicity was never due to the adhesive alone. For the PVAC sample, cytotoxicity was observed not only in the adhesive extract, but also in the extract from uncoated paper. For the positive acrylic samples, only the laminate extracts were cytotoxic, but not the adhesive or uncoated paper extract alone (MIGRESIVES 2010) . According to the authors, the cytotoxic effects observed could not be fully explained by the analytical data, requiring further investigation.
Cytotoxicity of plastics, silicone, and latex. The cytotoxicity studies with plastic FCMs assessed the cytotoxicity of poly(ethylene terephthalate) (PET) along with a few other plastic FCM types. In an early study, Sauvant and others (1995) assessed the cytotoxicity of water extracts of PET and polyvinyl chloride (PVC) materials throughout the different phases of the bottle manufacturing process. They used 4 acute cytotoxicity assays: TPC, NRU, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, and lactate dehydrogenase (LDH) release (Table 1A ). In addition, 1 sublethal cytotoxicity assay was performed, looking at RNA synthesis inhibition in the mouse fibroblast cell line L-929. The TPC assay was negative for all samples from all materials, while several production phase samples of PVC and PET showed cytotoxicity in various assays, PVC products most often. Final 'nonrinsed' PVC and PET bottles extracted with distilled water for up to 10 d or with natural mineral water for up to 24 mo, the latter condition also assessing glass bottles, did not show any cytotoxicity (Sauvant and others 1995) . However, in another experiment by the same group, cytotoxicity was observed in natural low-mineral content water stored in PET, PVC, and glass bottles for 18 mo and longer (up to 36 mo). Observed cytotoxicity was most frequent and highest in PVC>PET>glass (Sauvant and others 1994) . In this study, an acute toxicity assay with a protist Tetrahymena pyriformis (Table 1A) was used in addition to MTT, NRU, and RNA synthesis inhibition assays in L-929; the assay in protozoa and all assays in mammalian cells showed comparable toxicity profiles. Ergene and others (2008) , Ceretti and others (2010) , and Real and others (2015) assessed the cytotoxicity of commercially sold water bottled in PET or glass, either directly or after concentrating by means of the solid phase extraction (SPE) procedure. This experimental design does not allow unambiguously assigning the source of the observed toxicity, since the natural mineral water may have contained some toxic compounds already before bottling. However, one can compare the contribution of packaging materials to the differences in the observed toxicity, if any. Neither glass-nor plastic-bottled water samples showed any toxicity in either MTT assay with human breast cancer (MCF-7) or human prostate cancer (PALM) cell lines (Real and others 2015) or in the Microtox R test based on the naturally bioluminescent bacteria Vibrio fischeri (Table 1A ) (Ceretti and others 2010) . In the third study, delay in cellular growth and proliferation as measured by the reduction in the mitotic index (Table 1A) was observed in human blood lymphocytes exposed to the PET-bottled water (Ergene and others 2008) . However, here no comparison to glass or other materials was made, and the contamination source could not be identified.
In contrast to the study by Ceretti and others (2010) on PET and glass, which found no toxicity in the Microtox R test, in the same assay Szczepanska and others (2016) observed an up to 100% toxicity of water and artificial saline extracts from silicone and latex nipples, demonstrating the much lower inertness of these materials.
Genotoxicity
Genotoxicity refers to the ability of toxic agents to damage the genetic material in the cells. Under certain circumstances, this damage may result in cancer. In vitro genotoxicity testing is required by the EU and U.S. legislation as part of a dataset in support of most FCM authorization applications. Hence, genotoxicity as an important endpoint has also been often looked at in the studies assessing the toxicity of the overall FCM or FCA migrates or extracts. In vitro genotoxicity tests commonly assess the occurrence of DNA mutations, chromosomal aberrations, or alterations in DNA repair processes. Those assays that have been used for FCMs/FCAs testing are listed in Table 2A , and test results for various FCM types are summarized in Table 2B .
Genotoxicity of paper and paperboard. In a study by Binderup and others (2002) looking at virgin and recycled paper, none of the water extracts or 99% ethanol extracts gave positive results in the Ames test, both with and without metabolic activation (Table 2A, 2B ). Interestingly, 2 paper samples with the highest recycled fiber content showed equivocal results in the first trial, but a weak positive response observed could not be reproduced using a 3 times higher test concentration with 2 different concentrations of S9 mix (Binderup and others 2002) . In another study with food-grade and nonfood-grade virgin and recycled paper and board, water extracts and Tenax migrates extracted with ethanol 95% were negative in both the Ames test and the Comet assay (Table 2A) , the latter performed in the HepG2 cell line. Among ethanol extracts, only the one generated from a nonfood-grade paperboard sample (the only sample of this kind tested in the study) gave a positive response in the Ames test, but not in the Comet assay (Bradley and others 2008) .
Another study used the rec-assay (Table 2A) to test the ethanol reflux extracts of virgin and recycled food contact paper/board (Ozaki and others 2004) . Of virgin materials, only 19% of the tested samples were positive, while among the recycled materials, genotoxicity potential was detected in 75% of the extracts tested. Eight samples that were positive in the rec-assay were then tested with the Comet assay in the human promyelocytic leukemia (HL-60) cell line. Six of these samples proved to be positive also in the Comet assay, including all 3 samples prepared from virgin FCMs. Up to 20 different chemicals, including Michler's ketone and related benzophenone derivatives, hydroxyphenylpropane compounds, chlorophenols and other chlorinated aromatics, were detected in the extracts; their levels, however, were generally too low to explain the observed positive toxicological responses (Ozaki and others 2004) . A follow-up study by the same group represents one of the first examples of an effect-directed analysis applied to overall migrates/extracts from FCMs (Ozaki and others 2005) . Here, several positive samples were fractionated and retested with the rec-assay to identify the active fractions. Candidate chemical substances were then identified in the active fractions by means of chemical analytics. These substances were then individually tested in the rec-assay to confirm the absence or presence of the genotoxic potential. This approach resulted in the identification of dehydroabietic acid and abietic acid as potentially playing a role in the genotoxicity of paperboard FCMs observed in this study (Ozaki and others 2005) .
The samples obtained from 2 food-grade and 1 nonfood-grade cartons, brought into contact with Tenax and then extracted with ether, were negative in the BlueScreen assay (Table 2A ) (Koster and others 2014) . BlueScreen is a high-throughput luciferasemodification of the GreenScreen assay which detects several mechanisms of genetic damage based on an increased expression of the GADD45a gene in mammalian cells (Hughes and others 2012) . The use of the BlueScreen assay to confirm the absence of genotoxic substances in complex mixtures has been proposed as part of the Complex Mixture Safety Assessment Strategy (CoMSAS) for carton FCMs (Koster and others 2014) . However, although the BlueScreen test has been pre-validated with the use of the European Centre for the Validation of Alternative methods (ECVAM)-recommended set of genotoxic chemicals (Hughes and others 2012) , its ability to sensitively and specifically detect genotoxic compounds in a complex matrix of FCM migrates/extracts remains to be explicitly demonstrated. This could be done by using and comparing FCM extracts scoring positive and negative in other in vitro assays for genotoxicity, such as the Ames test, the rec-assay or the micronucleus (MN) assay.
Genotoxicity of coatings and adhesives. Ethanol extracts of epoxy coating and polyester coating tested negative in the Ames assay (Mittag and others 2006) . Both 10% ethanol and isooctane extracts of sol-gel coatings were also negative in the Ames test and in the test for chromosome aberrations, the MN test (Table 2A) carried out in HepG2 cells (Severin and others 2016) . Similarly, 95% ethanol extracts of 6 different paper-adhesive laminates were not genotoxic in the Ames test and Comet assay in HepG2 cells (MIGRESIVES 2010) .
Genotoxicity of plastics. Most of the studies looking at genotoxicity of plastic FCMs were performed with water stored in bottles made of PET, often compared with water stored in glass bottles. In 1990, De Fusco and others used the Ames test to investigate the leaching of mutagens from PET bottles into mineral water following short-and long-term storage in light or dark, with and without sample concentration by SPE (Table 2B) . PET-stored water was compared with glass-stored water from the same batch. Ames results were positive only for water kept in PET bottles for 1 mo, but not after 3 or 6 mo of storage. In the samples stored
In vitro toxicity testing of FCMs . . . in PET for a shorter time, namely for 2 d only, the mutagenic ratio could not be calculated because these samples were toxic to bacteria. The mutagenic activity detected in the water stored for 1 mo in PET was higher after storage in daylight compared with storage in the dark (De Fusco and others 1990) . A later study from the same group did not detect any increase in mutagenicity of mineral water stored in PET bottles for 1, 3, and 6 mo in daylight (Monarca and others 1994) . This discrepancy could, however, be explained by the differences in the bottle production process, since in the 2 studies, different PET bottle manufacturers were sourced.
Bach and colleagues did not detect any mutagenicity with Ames test or MN assay in HepG2 cells when testing mineral water stored in PET and glass bottles matched for the same water brand, or in the ultrapure water filled in the same bottles instead of the original mineral water, and kept for an additional 10 d either at 60°C (Bach and others 2013), or in sunlight (Bach and others 2014) . The authors also performed similar experiments at 40 and 50°C, and in sunlight for shorter durations, but they did not analyze these samples for genotoxicity. It has to be noted that 10 d is a rather short period, and although storage at 60°C was expected to accelerate the migration (Bach and others 2013) , this increase in temperature could have also led to degradation of potentially mutagenic compounds, thus decreasing the detection chances. Indeed, several other studies that looked at potential leaching of genotoxins from PET bottles after prolonged (at least several weeks) storage in 'mild' temperature conditions did observe genotoxic activity, in agreement with the original findings by De Fusco and others (1990) .
For example, a plant-based test, Allium cepa cytogenetics (Table 2A) , showed that at 8 wk after bottling mineral water stored in PET resulted in a higher frequency of cytogenetic aberrations in A. cepa root cells, compared with the same water stored in glass bottles (Evandri and others 2000) . Interestingly, in agreement with De Fusco and others (1990) , even higher frequencies were observed after storage in sunlight compared with storage in the dark. Similar findings with water stored in PET bottles for 2 mo in the daylight showing higher genotoxicity compared with that stored in the dark were reported by Ubomba-Jaswa and others (2010). Recently, a master thesis study in Kenya has used the Ames test to assess the genotoxic effects of water treated according to the solar disinfection (SODIS) procedure (McGuigan and others 1998), and found most water samples to show increased mutagenicity by day 60, followed by a decrease at day 90 (Moraa 2015) , again in agreement with De Fusco and others (1990) . Corneanu and others (2010) found that mineral water stored in PET bottles for 30 d after bottling (conditions unknown), followed by an additional 48 h either at room temperature or at 48°C, inhibited the growth of A. cepa roots, decreased the mitotic index value and resulted in an increased percentage of cells with chromosomal aberrations and metabolic disorders of chromosomes. Cytogenetic alterations were more pronounced in thermally treated samples compared with those stored at room temperature. The results of this study demonstrated that higher temperature enhanced the migration of clastogenic chemicals from PET into water, however, significant migration also occurred at room temperature (Corneanu and others 2010) .
Organic extracts of mineral (natural and carbonated) water obtained directly at the mineral water plant, filled in PET and stored in the dark, tested positive both in a Comet assay with human leukocytes and in a plant-based Tradescantia micronucleus test (Trad-MN, Table 2A ) after various storage times of up to 12 mo (Biscardi and others 2003) . However, the source water, not genotoxic at the spring site, tested positive for genotoxic activity in the Comet assay (but not in the Trad-MN test) after passing the distribution pipes but before bottling. Therefore, the authors suggested that the pipes, not the bottle, are the most likely source of water contamination with genotoxic compounds (Biscardi and others 2003) . In another study, several commercial PET-bottled drinking waters were tested after 8 wk of storage in a cytogenetic assay with human lymphocytes. Cytotoxic and cytostatic effects were found, possibly an indirect sign of genotoxicity. However, significant alterations of sister chromatid exchange frequency (the genotoxic endpoint looked at in this study) were not observed, only a slight induction trend (Ergene and others 2008) . Of note, the Organisation for Economic Cooperation and Development (OECD) has in 2014 considered the sister chromatic exchange test as obsolete due to availability of more efficient assays for the same type of genotoxic damage.
Ceretti and others (2010) used the same 2 tests as Biscardi and others (2003) , along with an A. cepa cytogenetics assay, to test unconcentrated still or carbonated mineral water after storage in PET or glass bottles for 10 d at 40°C (Ceretti and others 2010) . Genotoxicity was found in some samples, however, there was no clear pattern correlating with FCM type or storage regime. Instead, an association of positive in vitro genotoxicity results with the mineral content of the water has been suggested by the authors, but this trend could not be definitively confirmed due to a low number of samples tested (Ceretti and others 2010) .
Overall, it can be concluded that detection of genotoxicity in PET-bottled water appears to depend on the PET origin, the filling process and conditions of storage (such as light or temperature), and, last but not least, the duration of storage. Longer storage times without refilling tend to result in an accumulation of detectable genotoxicity in PET-bottled water, which can decrease again with even longer storage times in some cases. PET-bottled water can be stored for relatively long periods of time, and it is not possible to know when exactly during this storage period the bottled water will actually be consumed. Taking into account the storage time-and temperature-dependency of genotoxicity profiles observed in some studies, it may be necessary to introduce repeated testing at several time points during long-term storage at 'mild' conditions, as opposed to testing only at the end of shelf-life or after accelerated migration at higher temperatures.
Endocrine disruption potential
The endocrine system governs all physiological processes through its multilayer network of hormones and other signaling molecules. Endocrine disruption is the potential consequence of exposure to exogenous chemicals that may interfere with the endocrine system. Endocrine disrupting chemicals (EDCs) often act by mimicking or blocking the action of natural hormones, however, they may also affect hormone synthesis or transport, or interfere with feedback communication among different endocrine organs, among other means (Zoeller and others 2012) . In vitro tests assessing various pathways potentially contributing to endocrine disruption phenomena have been used for testing FCMs due to widespread concerns that FCMs can be a source of multiple EDCs (Muncke 2009; Sax 2010; Muncke 2011a; CwiekLudwicka and Ludwicki 2014; Muncke and others 2014; Simon and others 2016) . Chemical interaction with nuclear receptors represents the most important (and best studied) pathway for chemical interference with the endocrine system (Connolly and others 2011 hormone, or a hormone-mimicking xenobiotic), can regulate the expression of select responsive genes which in turn govern functions known to be controlled by the respective hormone. In studies with FCMs/FCAs, interactions with the estrogen receptor (ER) and androgen receptor (AR) have been assessed most often, but several other types of nuclear receptors have been looked at as well. Those assays that have been used for FCMs/FCAs testing are listed in Table 3A , and test results for various FCM types are summarized in Table 3B .
Endocrine disruption potential of paper and paperboard. Water extracts and ethanol extracts of virgin and recycled paper and paperboard FCMs have been tested for estrogenicity in several studies using either a yeast estrogen screen (YES) or a similar yeastbased bioassay, or a mammalian assay estrogen-screen (E-screen) that measures (xeno)estrogen-induced cell proliferation in MCF-7 cells (Table 3A) . Among the ethanol extracts of paper kitchen towels, 18% of products made of virgin fiber and 78% of those made with recycled fiber scored positive in YES (Vinggaard and others 2000) . However, in another study both water extracts and ethanol extracts of virgin and recycled paper and paperboard were cytotoxic to yeast cells even at high dilutions, thus precluding any meaningful estimation of estrogenic activity (Binderup and others 2002) . Such high toxicity to yeast could be due to fungicides which could have been added to virgin fibers already during the primary production. In a study with E-screen, 90% of ethanol extracts of paper and cardboard were estrogenic (Lopez-Espinosa and others 2007).
Water extracts and ethanol extracts of paper and paperboard have also been tested with aryl hydrocarbon receptor (AhR) Chemically Activated Luciferase eXpression (CALUX) assay developed for detecting dioxin-like chemicals (Table 3A) . Positive responses were observed in both water and ethanol extracts of several FCM samples; products with recycled fibers were more active than virgin ones (Binderup and others 2002; Bengtstroem and others 2014) . One positive extract obtained from a pizza box made of corrugated paperboard with recycled fibers has been subjected to effect-directed analysis comprising fractionation, retesting of fractions with AhR CALUX, and chemical analytics performed for all positive fractions (Bengtstroem and others 2016) . Subsequent nontargeted chemical analysis identified several chemicals as potentially AhR-active. In addition, several polychlorinated biphenyls, well-known dioxin-like chemicals, were measured with targeted analysis. However, the sum activity of all detected AhRactive compounds failed to explain the AhR activity measured in the bioassay. This led the authors to assume that the causative agents either remained unidentified, or the activity was due to the additive actions of multiple chemicals present at very low levels that escape detection and identification (Bengtstroem and others 2016) .
Endocrine disruption potential of coatings. In a study looking at nuclear receptor activity of coating extracts, isooctane extract and 10% ethanol extract from sol-gel coatings did not show any estrogenic activity in the reporter gene assay with transiently transfected human ERα in HepG2 cells (Severin and others 2016) . Another study focused on a novel polymeric coating derived from a bisphenol-based monomer, tetramethyl bisphenol F (TMBPF). This material was developed as a potential alternative to coatings based on bisphenol A (BPA), a monomer with an undesired estrogenic activity. The selection of TMBPF candidate for BPA replacement, aimed to be devoid of any estrogenicity, was guided by the Safety by Design assessment framework, which selected the estrogenic activity as one of the critical and testable biological effects, and used structure-activity relationships to predict that TMBPF is unlikely to bind to the ER. Both 50% ethanol extract and 3% acetic acid extract tested negative in the E-screen assay, as did the monomer itself in this and several other in vitro and in vivo assays for estrogenicity (Soto and others 2017) .
Endocrine disruption potential of FCMs used for storing drinking water. Potential migration of EDCs from PET bottles has received a lot of attention, being the subject of much controversy among the different scientific groups (Bach and others 2012) . With the YES assay, less than 10% of commercial PET-bottled waters sampled in Italy were positive (Pinto and Reali 2009 ). However, >60% of water concentrates in this study were in fact cytotoxic to yeast, what may have complicated the detection of specific estrogenic responses. In another study surveying German mineral water bottled in glass, PET, and TetraPak, estrogenicity in YES assay was detected in 33%, 78%, and 100% of the respective samples (Wagner and Oehlmann 2009) . Several water brands showed estrogenicity regardless of the bottle (glass or PET), suggesting that the water could have been contaminated before bottling. Generally, however, mineral water bottled in plastic showed more frequent and higher estrogenic activity than waters bottled in glass, suggesting a contribution from the packaging material (Wagner and Oehlmann 2009) . Similar results were obtained by the same authors on another set of samples when using an E-screen (Wagner and Oehlmann 2011) , while another group that used this assay found some estrogenic activity in about 20% of samples of PET-stored waters tested, with an increase in estrogenic activity detected when retesting the same waters after >6 mo of storage (Boehmler and others 2006) . In contrast, several other studies using mammalian cell-based luciferase reporter gene assays reported the absence of estrogenic activity in commercially sold drinking water bottled in PET (Maggioni and others 2013) or bottled in glass or PET and subjected either to sunlight (Bach and others 2014) or temperature (Bach and others 2013; Chevolleau and others 2016) treatments. Ethanol extracts of PET also showed no estrogenic activity with YES (Kirchnawy and others 2013) and ER CALUX (Table 3A ) (Mertl and others 2014) . Chevolleau and others (2016) also reported the absence of compounds that could activate AR, progesterone receptor (PR), glucocorticoid receptor (GR), or thyroid receptor alpha (TRα), as tested with the respective reporter gene assays. They suggested that the endocrine activity associated with PET FCM by several studies could be due to contamination during sample concentration, which can be avoided by using only materials made exclusively of glass, Teflon or stainless steel during analytical procedure (Chevolleau and others 2016) . However, it has to be noted that previous studies have always included identically treated blank controls in their experiments, and these have demonstrated negative responses following identical concentration and sample treatment procedures. Alternative explanations for the differing results could be the differences in source PET materials, as well as the differences in the storage duration and temperature conditions of bottled water applied before testing, but also the potential loss of substances during the extraction procedure, as well as the differing sensitivity of in vitro bioassays applied.
Several more studies have assessed the presence of nuclear receptor agonists and antagonists in bottled water. However, in most of these studies the brands of water have not been matched for different packaging materials, therefore making conclusions on the contamination sources is not always possible. For example, ER activity as well as activities on 3 other nuclear receptors, AR, PR, and GR, were detected in a large proportion of commercial bottled waters In vitro toxicity testing of FCMs . . . purchased in the Belfast region of the UK (Plotan and others  2013) . However, the activity was observed in both PET-and glass-bottled samples (not of the same brand), and it has been suggested that, at least in some cases, it could be due to flavors and other additives in water rather than to the packaging material itself. In another study performed in Spain, (antiestrogenic) and (anti-androgenic) activity was assessed with an E-screen and human prostate cancer PALM cells, respectively. Estrogenic, anti-estrogenic, and androgenic activity was detected in plastics (mostly PET)-stored waters, but also occasionally in glass-stored waters (not of the same brand), indicating that there could be sources of contamination other than from the bottle material (Real and others 2015) . Interestingly, however, the anti-androgenic activity was detected only in PET-stored waters (41%, 12 out of 26 bottles tested). In German PET-and glassbottled water, anti-estrogenic and anti-androgenic activities have been found with the yeast anti-estrogen screen (YAES; 70% of samples positive) and yeast anti-androgen screen (YAAS; 90% of samples positive) (Wagner and others 2013) . In this study, nontargeted chemical analysis pointed toward maleate and fumarate isomers as the candidate chemicals responsible for anti-androgenic activity in the samples. In commercial drinking water obtained in Finland, bottled in an unreported FCM, no estrogenic activity was found using a yeast-based bioassay (Omoruyi and Pohjanvirta 2015) , while a positive response was detected with the same assay in 31% of pure drinking water in Nigeria, packed in plastic sachets (no further specification reported) (Omoruyi and others 2014).
Endocrine disruption potential of plastics, silicone, and latex.
In addition to studies focused on bottled water only, with frequent uncertainties regarding the water sources, there have been several investigations of the potential leaching of endocrine active compounds from PET and other plastics where extraction was carried out in a more controlled laboratory environment. Kirchnawy and others (2013) used the YES assay with which the estrogenic activity of ethanol extracts could be detected in 4 out of 7 FCAs made of composite film (CF) and one of each from 9 polystyrene (PS), 7 polypropylene (PP), and 8 polyethylene (PE)-made products (Kirchnawy and others 2013) . Another study detected estrogenicity with both YES and ERα CALUX assays in 95% ethanol extracts of 2 out of 3 CF, and 1 out of 3 each of PP and PS. In 2 more PS products, an estrogenic response was observed with the ER CALUX assay only. Anti-estrogenicity with YAES was observed in one each of the 3 PS, PP, and PE products, and in 2 out of 3 food carton products (milk packaging), but none of the samples showed anti-estrogenicity in the ERα CALUX assay (Mertl and others 2014) . Androgenic activity was not detected in any of the products with any of the 2 assays, yeast androgen screen (YAS) and AR CALUX (Table 3A) . Anti-androgenic activity was observed in 2 out of 3 products of each CF, PS, PP, PE, and food carton categories, but of these only 1 PS product showed anti-androgenicity also in the AR CALUX assay. Unconcentrated water extracts of polycarbonate (PC) and Tritan TM plastics tested negative in various yeast-based bioassays, including those for ER and AR (agonistic and antagonistic), as well as retinoic acid receptor (RAR) and vitamin D receptor (VDR) (Guart and others 2013) . Szczepanska and others (2016) used the YES/YAES and YAS/YAAS to test the endocrine activity potential of the water extracts and artificial saliva extracts of baby nipples made of silicon and latex. Anti-androgenic activity was detected in all samples and was especially strong in the extracts obtained within the first 2 h of FCM contact with solvents.
Several more studies used mammalian cell-based assays, E-screen and BG1Luc (Table 3A) to investigate the leaching of the estrogenic activity from a large number of FCMs/FCAs made of various plastics, including PET, PE, PP, PC, PS and polylactic acid (PLA) (Yang and others 2011) , and a broad selection of PC-alternative FCMs others 2014a, 2014b) . The latter 2 studies demonstrated that the label 'BPA-free' does not necessarily mean 'estrogenic-activity free'. Plastics were extracted with water, saline, or ethanol, and subjected to various stresses, including autoclaving, microwaving and UV radiation, used to simulate the wear during real-life use. Significant estrogenic activity was found in a majority of FCMs/FCAs tested, with a probability of detection increasing when different solvents and/or different stress conditions were applied to the same samples (Yang and others 2011; Bittner and others 2014a) . Sensitivity of the MCF-7 and BG1Luc assays also varied with different products, however, the final conclusion on the estrogenicity of a given sample made through both systems correlated in most of the samples (Bittner and others 2014b).
Toxicity tests with small multicellular animals
Clear advantages of cell-based in vitro bioassays compared with in vivo tests in mammals include much lower time and resource requirements, as well as reduction of animal use in toxicity testing. However, important disadvantages include the absence of the whole-organism context, such as interactions and communication between different cell types, tissues and organs, as well as the oftenreduced metabolic capacities and the inability to detect multiple apical responses. Toxicity tests with small multicellular animals may use invertebrates such as water fleas or snails, or vertebrates such as fish embryos. These assays provide an opportunity to combine the most favorable characteristics of both systems, in vivo and in vitro. While already featuring the complexity of whole-organism interactions, they remain relatively inexpensive, fast and easy to perform, and thus amenable to high-throughput screening on the scale comparable to cell-based in vitro bioassays. Moreover, most bioassays with small multicellular animals are legally considered to be nonanimal tests, not requiring animal experiment authorization. The small multicellular animal bioassays that have been used for FCMs/FCAs testing are listed in Table 4A , and test results are summarized in Table 4B .
Most of the available studies have focused on plastics. Lithner and others (2009) used the acute immobilization test with water flea Daphnia magna (Table 4A) to test the unconcentrated water extracts (leachates) from several plastic FCAs, including a PS cup, a plate made of melamine resin, a baking sheet coated with polytetrafluoroethylene (PTFE), and several types of water pipes made of medium-and high-density polyethylene (MDPE and HDPE), acrylonitrile butadiene styrene (ABS), PP, or PVC. All samples were negative in this test (Lithner and others 2009 ). Salty water extracts from a PS cup and a soda bottle made of bio-PET also tested negative in an assay with another invertebrate, Nitocra spinipes (Table 4A ) (Bejgarn and others 2015) . In contrast, both water and artificial saliva extracts from silicone and latex nipples caused a very strong growth inhibition in the ostracode Heterocypris incongruens (Table 4A ), demonstrating that these FCMs may not be inert and appear to release high amounts of toxic substances, particularly within the first 2 h of contact (Szczepanska and others 2016) . Wagner and Oehlmann (2009) used the mud snail Potamopyrgus antipodarum reproduction assay (Table 4A) to compare the estrogenic activity of the substances migrating from PET and glass. Compared with the snails cultured in the glass bottles, those cultured in PET produced a significantly higher (Table 4A) , has investigated the toxicity of ethanol extracts of epoxy and polyester coating. Only the latter was found to induce mortality at higher concentrations, and sublethal malformations such as spin deformations and edemas at lower concentrations (Mittag and others 2006) .
Overall, these studies have demonstrated the suitability and value of small multicellular animal-based bioassays for assessing the acute toxicity, teratogenicity, and potential endocrine activity of FCM extracts. These model systems can provide useful information on both human health and ecological effects of FCMs, and hence their potential addition to the panel of 'conventional' in vitro tests for FCMs testing should be considered.
FCM Testing in vitro: Future Research Needs
The studies reviewed above have demonstrated that applying in vitro bioassays to test the toxicity of FCMs/FCAs is in principle feasible. Hence, such an approach to ensuring FCM safety and controlling FCM compliance appears promising, as suggested by others (Muncke 2011b; Koster and others 2015) . However, before a broader application of this approach becomes possible, further development of test procedures, as well as workflow optimization, are necessary. We discuss 2 crucial aspects concerning sample preparation and assay selection.
Sample preparation
The procedures for preparing representative samples for in vitro testing of paper and paperboard FCMs have been optimized in the BIOSAFEPAPER project (Bradley and others 2010; HonkalampiHämäläinen and others 2010) . This work has been incorporated into industry guidelines for testing compliance of paper and board FCMs based on cytotoxicity assays carried out with water extracts (EN 15845, EN 16418) (Koster and others 2015) . However, for other FCMs no consensus on standard protocols for preparing representative samples for in vitro testing has been reached so far.
In principle, the suitability of both water and organic extracts for use in most of the downstream in vitro testing applications has been demonstrated not only for paper and board FCMs, but also for adhesives (MIGRESIVES 2010) , coatings (Mittag and others 2006; Severin and others 2016) , and various types of plastics (Guart and others 2013; Bittner and others 2014b; Berger and others 2015) , including bio-based plastics (EU Ecopack project, www.ecopack-label.eu). However, a number of aspects need to be agreed on. These include the selection of solvents, time, and temperature conditions for migration/extraction experiment, as well as the subsequent sample work-up procedures, such as clean-up, SPE, fractionation, or affinity purification techniques, that may be used to concentrate the analytes in order to overcome the "masking" of specific effects by nonspecific toxicity. The efficiency and reliability of different techniques should also be investigated in more detail with the goal of method optimization (Wagner and others 2013) . In particular, it should be ensured that no external contamination occurs but also that there is no loss of relevant compounds, such as loss of volatiles during evaporation or hydrophobic compounds due to surface sorption (Wagner and Oehlmann 2011; Chevolleau and others 2016) . Further, the application of innovative techniques, such as for example the thin layer chromatography directly coupled with in vitro bioassays (Buchinger and others 2013) , could be considered and tested. Ideally, the optimized procedures for each FCM type should become not only standardized, but also internationally harmonized, as this would allow for better comparisons across different studies and laboratories, and ensure mutual acceptance of test results.
The studies reviewed above have successfully used various media and solvents for preparing FCM extracts or migrates for in vitro testing, including distilled water, tap water, mineral water, saline, and various organic solvents such as ethanol (10-99%), methanol, ethane, n-heptane, and isooctane. Migration into vegetable oil has not been used in any of the studies reviewed, however, migration into isooctane or 50% ethanol was employed to simulate migration into fatty foods instead. Several studies have observed higher activity in the organic and more hydrophobic ethanol extracts compared to the water extracts. This is most often the case because many organic chemicals present in FCMs have a rather low water solubility. However, in some cases both types of extracts exhibited their own unique toxicity profiles, demonstrating that both hydrophilic and hydrophobic as well as polar and nonpolar groups of compounds may be contributing to the observed toxicity (Bradley and others 2008; Bradley and others 2010) . Hence, the use of different extraction procedures may increase the probability of detecting significant positive responses, thus helping to reduce the rate of false negatives, as has indeed been demonstrated for example by Bittner and others (2014b) . Migration into dry foods has been simulated by performing migration testing into Tenax followed by Tenax extraction with 95% ethanol; these samples always tested negative in cytotoxicity and genotoxicity assays (Bradley and others 2008) . Since it is possible that some of the potentially toxic volatile chemicals have been lost during the subsequent extraction of Tenax with 95% ethanol, this protocol may require further optimization as well.
For the sake of comparability, standardization and harmonization, it would be advisable that future studies working on establishing in vitro test-based workflows for assessing the safety of FCMs/FCAs use the solvents and procedures outlined by the relevant regulations, for example the Regulation (EU) 10/2011 (EC 2011), or guidelines issued by the regulatory authorities, for example the U.S. Food and Drug Administration (FDA 2002) . Most of the solvents currently recommended as food simulants in the EU or U.S., with the exception of vegetable oil, appear to be suitable for use in in vitro bioassays either directly, or after transferring into a more compatible solvent such as dimethyl sulfoxide (DMSO).
However, particularly in the situations when the food type and conditions of use are unknown, it may be rather impractical to test the materials with all possible solvents and conditions intended to simulate real-life migration into foods. In this case, the more preferable option would be to apply one or a few, for example polar and nonpolar, extraction protocols (Franz and Störmer 2008; McCombie and others 2016) , as this would be more cost and time efficient. Hence, it would be helpful if a certain "worsecase" extraction procedure for the specific types of FCMs was agreed on by all stakeholders. This procedure should allow for efficiently obtaining a mixture of all chemicals, including emerging and unknown contaminants, that could possibly migrate from a given FCM/FCA into food under all foreseeable conditions of use (Feigenbaum and others 1997) . When designing the extraction or migration conditions, it has to be taken into account that certain solvent/FCM combinations may cause FCM damage, resulting in an increased mass transfer of FCCs, an example being the swelling of PET in ethanol solutions as low as 20% ethanol (Franz and C In vitro toxicity testing of FCMs . . . others 2016). Hence, the benefits and disadvantages of accepting a harsh extraction procedure for the sake of obtaining a mixture of all potential migrants should be carefully considered. Indeed, although a complete extraction procedure for a given FCM type would most likely overestimate the real-use migration into food, it nonetheless may provide an efficient means of obtaining representative samples to perform low-tier screening-like in vitro testing for a large number of samples. The positive samples from such extraction-based screens can then be flagged for further assessment with the use of milder migration conditions more closely reflecting the anticipated conditions of use. Such an approach could be integrated in the strategy suggested for testing FCM compliance with overall and specific migration limits (Feigenbaum and others 1997; Franz and Störmer 2008) . Another argument for the preferred use of extraction procedures concerns the fact that even those FCCs for which a negligible migration from virgin FCMs can be demonstrated, may nonetheless pose a problem due to accumulation in recycled FCMs or following their release into the environment upon (improper) disposal. Therefore, the use of "worse case" extraction approaches may provide the means for the broadest coverage of the potentially problematic FCCs with the least investment in terms of time and resources required.
Assay selection
Assay selection is the second aspect that needs to be carefully considered when using in vitro testing to ensure FCMs/FCAs safety. Ideally, all stakeholders would agree on the choice of adequate assays, along with guidance for a transparent interpretation of test results, as this will be crucial for successful application of this approach.
Despite their advantages, in vitro bioassays have several limitations, some relevant specifically for FCM testing and others shared by all in vitro toxicity testing approaches in general. One limitation with regard to FCM testing concerns the fact that the substances and substance mixtures tested in vitro would not be subject to influences from food components and from the human digestion processes. The former issue may be addressed by using proper food simulants or by modeling. Regarding the latter aspect, it may be possible, where relevant, to establish a procedure where FCM extracts or migrates are additionally subjected to simulated digestion prior to in vitro testing. Nanomaterials may represent one example of an FCM where adding this layer of complexity may be particularly crucial to ensure a reliable reflection of potential toxicity (Lichtenstein and others 2015; Fröhlich and Roblegg 2016) . The general challenges in application of in vitro testing for prediction of in vivo toxicity include the lack of complete understanding of toxicokinetic processes, lack of xenobiotic metabolism capacity in most in vitro models, and absence of interactions present within a complex multicellular organism. There are also difficulties in predicting chronic exposure effects from in vitro data, and challenges in extrapolating in vitro findings to human health-relevant in vivo endpoints (McKim 2010 ), which in turn should be linked to the most relevant diseases of public concern. The general challenges and potential solutions for improving the in vivo relevance of in vitro testing in general will not be further addressed here, as they have been reviewed elsewhere (Eisenbrand and others 2002; van Vliet 2011; Astashkina and others 2012; Leist and others 2014; Knudsen and others 2015; Blaauboer and others 2016) .
Next, we will discuss the issue of bioassays' sensitivity and specificity, and suggest a few potentially useful additions to the panel of FCM-relevant in vitro bioassays.
Sensitivity and specificity of in vitro bioassays. Combined chemical and biological analyses have repeatedly shown that the total activity of all compounds detected by chemical analytics (calculated as a function of potency and concentration) often fails to fully explain the observed biological response (HonkalampiHämäläinen and others 2010; Bergamasco and others 2011; Wagner and others 2013; Bengtstroem and others 2016) . This shows that many bioassays may prove to be more sensitive than the chemical analytics alone, likely because bioassays may detect (i) effects at lower concentrations, (ii) effects of additional compounds not identified chemically, or (iii) effects governed by chemical interactions not easily predicted from chemical identities, such as synergism.
However, genotoxicity bioassays are an important exception to this rule, because those currently available and most often used still have an inferior concentration sensitivity compared to the targeted chemical analytics (Koster and others 2014; Koster and others 2015) . This can be illustrated by the example of primary aromatic amines (PAAs), which are known mutagens. In the plastics FCM regulation (EU) 10/2011, the analytical limit of detection for the sum of released PAAs, excluding those specifically mentioned in the Annex I, is set to 10 μg per kg of food or food simulant (EC 2011). One of the strongest directly acting mutagens among the PAAs is 4-nitro-o-phenylenediamine. In the Ames test, it is used as positive control at a concentration of 125 μg/L (Mortelmans and Zeiger 2000) . Mittag and others (2006) showed that, using common extraction procedures, it is not feasible to reach this positive control concentration in the Ames test by concentrating the extracts of FCMs, even if these would contain PAAs at the highest legally allowed level (Mittag and others 2006) . Further, with regard to NIAS assessment, in the Threshold of Toxicological Concern (TTC) approach the limit for the potentially genotoxic substances is set at 0.15 μg per person per day, which corresponds to 0.0025 μg/kg bw/d (Kroes and others 2004) . This concentration level would be impossible to monitor in FCMs using the state-of-the-art combination of extraction methods and in vitro bioassays, as has been emphasized for example by Koster and others (2014) who used the BlueScreen genotoxicity assay. Indeed, "up-concentrating" a compound present at a low level in FCMs would require that, instead of extracting from 6 dm 2 or even a smaller surface often used in practice, it may be necessary to extract from much larger surfaces (for example, 200 dm 2 ). However, concentrating the target analytes in this fashion would mean that all other simultaneously present compounds are also similarly "up-concentrated." The resulting complex mixture would thus have a higher probability of causing unacceptable levels of nonspecific cytotoxicity before any of the more specific effects of interest, such as genotoxicity or endocrine activity, can be observed and quantified. A solution to this could be to fractionate the "up-concentrated" extracts. However, this would result in additional costs for testing all fractions. Hence, if in vitro genotoxicity bioassays, including the recently proposed ones such as BlueScreen (Hughes and others 2012) or ToxTracker (Ates and others 2016) , are to be reliably used in routine screening of overall extracts from FCMs/FCAs, efforts on improving and evaluating their concentration sensitivity and performance in complex FCM extracts should be further undertaken. An interim solution until more sensitive bioassays are available would be to complement the bioassay-based workflow with a targeted chemical analysis for known chemicals of concern or classes of chemicals of concern (Koster and others 2014) . For example, Kroes and others (2004) concern for genotoxicity at the lowest exposure threshold (0.15 μg per person per day), which could be controlled by chemical analytics. These 5 groups include 3 groups of genotoxic carcinogens, namely aflatoxin-like compounds, N-nitroso-compounds, azoxy-compounds, and 2 groups of nongenotoxic carcinogens, namely steroids, and polyhalogenated dibenzo-p-dioxins and -dibenzofurans.
Apart from the need to be sufficiently sensitive to detect biological effects at a relevant concentration (that is, have a low rate of false negatives), an in vitro bioassay should also demonstrate a sufficient specificity (that is, have a low rate of false positives). This can be illustrated by the example of yeast-and mammalian cell-based assays for assessing interaction with the ER (YES and ER CALUX, respectively). Both assays can be applied to detect agonistic effects (ER activation), and report similar trends in estrogenic activity. However, YES has an order of magnitude lower sensitivity and therefore is more prone to false negatives (Leusch and others 2010; Mertl and others 2014) . With regard to the antagonistic effects (that is, ER inhibition, or blocking), on the contrary, Mertl and others (2014) observed that a large proportion of FCM extracts tested positive in the yeast-based assay (YAES), but showed no effect in the mammalian cells (anti-ER CALUX). Similar observations were made for anti-androgenic effects in YAAS and anti-AR CALUX tests. Hence, Mertl and co-authors concluded that their findings on the antagonistic activity represent yeast-specific interactions, and judged them to be false positives and irrelevant for predicting human health effects (Mertl and others 2014 ). This conclusion is in line with the OECD's guidance on endocrine disruption assays which has highlighted several limitations of yeast-based assays, such as sensitivity to fungicides and issues with permeability across the cells wall, and therefore suggested that human cell-based assays should be preferred (OECD 2012a) . However, the antagonistic responses observed by Mertl and colleagues in YAES and YAAS were receptor-specific, and unspecific effects such as suppression of beta-galactosidase expression and activity could be excluded. Therefore, it could also be that, compared with the CALUX assays, yeast-based assays have a superior sensitivity for detecting the ER-and AR-antagonistic activity in the complex matrix of plastic FCM extracts. Hence, positive YAES or YAAS findings should not be simply dismissed as unspecific, but may require further investigation. In support of this, the effect-directed analysis triggered by the YAAS-based detection of anti-androgenic activity in the methanol extract of a plastic baby teething ring allowed identifying several parabens as being responsible for this effect (Berger and others 2015) . Parabens are indeed known to possess a weak anti-androgenic activity (Chen and others 2007) , and Wang and others (2014) detected anti-androgenic effects of butyl paraben in both anti-AR CALUX and YAES tests within the same study.
Another example concerns genotoxicity testing with plantbased systems, such as A. cepa cytogenetics or Trad-MN tests. Although the current international guidelines do not consider plant systems as primary screening tools where results can be extrapolated to mammals, these tests have nonetheless shown a considerably high specificity and good agreement with mammalian assays (Kristen 1997) . Cost-efficient plant-based tests could be considered for application in FCMs screening, however further clarification on their usefulness for human risk assessment would be necessary.
The type of mammalian cells used in the in vitro bioassay may also significantly influence the test results, making it one of the most important variables determining the sensitivity and specificity of an in vitro test (Severin and others 2005; Laffon and others 2017) . Toxicity in primary cells may differ from toxicity in permanent cell lines subject to multiple passages (Krebs and others 2002; Pan and others 2009) , and the sensitivity of cancer cells often differs from the sensitivity of noncancer cells originating from the same tissue (Guo and others 2011; Krog Frandsen and others 2016) . Another factor to consider is the metabolic activity of the cells. For example, the HepG2 cell line is known to possess residual metabolic activity. This may result in this cell line showing a lower sensitivity, possibly due to biotransformation and detoxification, conferring protection from certain xenobiotics (Mittag and others 2006) . However, this feature could also be seen as an advantage since the in vitro results obtained with the metabolically competent cell line may be more relevant to the in vivo situation, thus helping to reduce the rate of false positives detected in vitro. Metabolic capacity of in vitro systems can be improved by adding the preparations containing biotransformation enzymes, such as S9 fractions. This is commonly done for example in the bacterial Ames test (Mortelmans and Zeiger 2000) , but is also applicable to mammalian cell-based assays (Mollergues and others 2017) . Overall, the issue of assay sensitivity versus specificity needs to be carefully considered. Hence, ideally, the most suitable in vitro model should be chosen after performing comparative studies evaluating several assays and cell types with multiple FCMs.
Expanding the panel of FCM-relevant in vitro bioassays. For in vitro bioassays to become more broadly applied in the routine screening of FCMs/FCAs, it would be necessary to define the thresholds above which a follow-up action should be initiated. Important to keep in mind here is the issue of cytotoxicity: no specific activities, such as mutagenicity or endocrine activity, can be considered reliably positive when measured at concentrations causing unacceptable levels of cytotoxicity. Further, the interpretation of assay results to be applied in determining FCM safety would require that a clear relationship between the observed in vitro response and an in vivo endpoint relevant for human health has been established. For example, trigger values for drinking water samples have been developed for CALUX bioassays measuring activity with the hormone receptors ER, AR, PR, and GR, defining a level above which an additional examination of a specific endocrine activity may be required because a potential risk to human health cannot be excluded (Brand and others 2013) . A similar approach relying on specific trigger values could be developed for testing the safety of different FCMs/FCAs types.
However, the work on in vitro to in vivo extrapolation, establishment of trigger values, integrated testing strategies and related workflows is typically very time-and resource-consuming (Yoon and others 2012; Blaauboer 2015; Wetmore 2015) . Therefore, before investing in this type of further framework development, it should be first ensured that the in vitro bioassays in focus are indeed the most suitable, the most comprehensive, and the most relevant for assessing FCMs. To meet this goal, the battery of previously used bioassays may need to be expanded to cover additional relevant mechanisms of cellular toxicity such as for example oxidative stress (van der Linden and others 2014), and to enable better prediction of chronic toxicity outcomes focused on organ-or disease-specific toxic effects. It should also be ensured that the chosen in vitro tests can be linked to in vivo toxicity outcomes, covering all endpoints of imminent human health relevance (for example, noncommunicable diseases caused by chemical exposures). For example, an array of in vitro tests aimed at detection of genotoxicity should be complemented by an assay for In vitro toxicity testing of FCMs . . . detecting nongenotoxic carcinogens, such as a cell transformation assay (Corvi and others 2012) .
With regard to testing for potential endocrine activity, our review has shown that, despite the relatively high number of dedicated publications and a variety of individual assays used, most of the assessed endpoints focus on transactivation or inhibition of only a few well-studied nuclear receptors. This problem is not specific to FCMs testing, but rather concerns the current status of the whole field of endocrine disruption research in general (Wagner 2016) , as well as in vitro approaches to studying endocrine disruption potential in particular (Wagner and others 2017) . Given the complexity of interactions between endocrine system and xenobiotics, often not grasped by the limited coverage of presently available in vitro tests (Giebner and others 2016) , the current research focusing on only a few chemicals and endpoints needs to be broadened. Indeed, it has been shown, for example, that expanding in vitro estrogenicity testing with assays for antiandrogenicity, as well as for the effects on steroidogenesis, allowed detecting a much broader set of potential endocrine disrupting effects. In this expanded panel, several estrogenic model compounds have demonstrated additional activity, suggesting that such co-occurring actions could contribute to potentiating their effects in vivo as well (Wang and others 2014) .
Supporting the relevance of the H295R steroidogenesis assay for FCMs testing, it can be noted that steroidogenesis can be disrupted by certain phthalates (Boisvert and others 2016) and bisphenols (Rosenmai and others 2014) , both compound groups well-known to migrate from various FCMs (Bhunia and others 2013) . Also, several per-and polyfluorinated substances (PFASs), widely used in food packaging (Schaider and others 2017) , were shown to decrease the levels of androgens and progestogens, and increase the levels of cortisol and estrogens in the H295R steroidogenesis assay (Rosenmai and others 2013) . Among the different nuclear receptor types, FCM studies have most often addressed the ER, AR and AhR. However, several other nuclear receptors may also be affected by FCCs (Karmaus and others 2016) . For example, peroxisome proliferator-activating receptors (PPARs) are known to play important roles in metabolic disorders and obesity (Janesick and Blumberg 2016) , two important chronic conditions of very high public health relevance. The ability to strongly activate the PPAR(s) has been shown for both FCM extracts (Rosenmai 2014) and individually tested FCCs, for example for FCCs demonstrated to migrate from PC-alternative plastic baby bottles (Simon and others 2016) , and for select PFASs (Rosenmai and others 2016) . Other nuclear receptors, such as PR, TR or GR (Ghisari and Bonefeld-Jorgensen 2009; Simon and others 2016) , but also a second isoform of ER, ERβ (Matthews and others 2001; Liang and others 2014) , as well as the membrane form of ER, G-protein coupled estrogen receptor (GPER) (Pappas and others 1995; Ropero and others 2012; Levin 2015; Nadal and others 2017) , may also be of relevance, and should be investigated further for their responses to FCM extracts. Suitable in vitro assays covering a broader variety of nuclear receptors are available from both commercial and academic developers (Schug and others 2013; van der Burg and others 2013; Grimaldi and others 2015) .
As the research community moves toward a better understanding of the complexity of xenobiotic interactions with the endocrine system, further mechanisms and additional important endpoints of relevance for assessing the endocrine disruption potential in vitro may be identified (Wagner 2016) . However, apart from endocrine disruption per se (Vandenberg and others 2012; Gore and others 2015) , as well as its most-studied links to reproductive system-related outcomes (Fowler and others 2012; Yoon and others 2014; Boisvert and others 2016) , many other harmful effects of chemicals, including some FCCs, have been reported. These effects include, for example, developmental and neurobehavioral disorders (Maffini and Neltner 2014; Maffini and others 2016) , interactions with gut microbiota (Snedeker and Hay 2012; Lu and others 2015; Hu and others 2016) , metabolic disruption leading to obesity and diabetes (Alonso-Magdalena and others 2011; Auerbach and others 2016; Braun 2016; Heindel and others 2017), cardiovascular diseases (Yan and others 2011; Mariana and others 2016) , immune disorders (Rogers and others 2013; Thompson and others 2015; NTP 2016) , and carcinogenesis-relevant pathways (Soto and Sonnenschein 2010; Seachrist and others 2016; Smith and others 2016) . Upon consideration, the endpoints relevant for these effects should be evaluated for inclusion in the in vitro panel for FCMs testing as well. It has been stated that the choice of in vitro bioassays for NIAS assessment of specific FCMs should be based on expert judgement (Koster and others 2015) . In order to close current knowledge gaps and ensure FCM safety, experts and scientists from all relevant fields of expertise, as well as representatives of the different stakeholder groups, should become involved in the development of a unified approach to in vitro testing of FCMs.
Conclusions
The studies reviewed here have demonstrated that using in vitro bioassays to test the toxicity of FCMs and FCAs is in principle possible. In vitro bioassay-based testing allows for a rapid evaluation of multiple toxicological endpoints, allowing to measure a combined effect of all substances, including the unknowns, present in the complex mixture. However, moving toward a broader application of this approach to assessing FCM safety requires solving several remaining challenges along the way. Firstly, the procedures for obtaining representative samples of various FCM types for in vitro testing should be optimized, standardized, and harmonized. Two main types of contact conditions could be used, extraction-like (involving an intense interaction resulting in a quick and complete mass transfer of all possible migrants) and migration-like (relying on typically milder conditions, more resembling of actual use conditions). Among these 2, the quick and comprehensive extraction appears to be the most pragmatic approach, largely because such experiments would be more comprehensive, more cost-efficient, and simpler to perform. However, the possibility of overestimating effects should be taken into account, for example by a follow-up migration-based testing of positive FCM samples. Another area in need of additional research concerns the selection of in vitro bioassays, as well as the interpretation of the test results. Assays for FCMs testing need to be of sufficient sensitivity for detecting all chemicals of concern at FCM-relevant concentrations. Furthermore, in vitro tests should provide a measure of specific responses reflective of in vivo endpoints with a clear human health relevance. Currently, much research is being conducted to obtain a better understanding of environmental determinants of human diseases of public concern, and the knowledge of pathways involved should be considered when selecting the most appropriate in vitro bioassays and agreeing on their interpretation. Ensuring the in vivo relevance of in vitro assays is crucial for establishing a reliable framework for in vitro bioassay-based testing of FCM safety.
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